Q2 2026 · CIK 1569205 Snapshot · — Export CSV
Manager file · FS · Fundsmith LLP

Terry Smith - Fundsmith

EDGAR CIK 1569205 ↗ · Filed · typical filing lag 45 days

Export CSV
Reported portfolio value
$13.65B
QoQ reported +6.4% · vs Q1 2026
Positions
41
13 new · 6 exited
Top 10 concentration
52.5%
largest position 7.0%
Position churn · Q2 2026
4 added · 21 trimmed
new positions 30.4% · exits 0.0% of book
Holdings · Q2 2026 · 41
Security Weight Δ wt Price* Shares Δ shares Value Action
1 MAR MARRIOTT INTL INC NEW 7.02% -1.6% $371 2.59M -23.3% $958M Trimmed
2 SYK STRYKER CORPORATION 6.72% -1.1% $315 2.91M -4.8% $917M Trimmed
3 WAT WATERS CORP 6.25% -1.2% $375 2.27M -29.2% $853M Trimmed
4 V VISA INC 5.08% -2.2% $343 2.02M -34.9% $693M Trimmed
5 UBER UBER TECHNOLOGIES INC 4.73% +4.7% $72 8.94M new $645M New
6 MA MASTERCARD INCORPORATED 4.69% +4.7% $514 1.25M new $639M New
7 GOOGL ALPHABET INC 4.64% -2.0% $357 1.77M -40.0% $634M Trimmed
8 CHD CHURCH & DWIGHT CO INC 4.58% -0.2% $97 6.46M -2.8% $626M Trimmed
9 PG PROCTER & GAMBLE CO 4.38% -0.3% $147 4.08M -2.9% $598M Trimmed
10 MSFT MICROSOFT CORP 4.36% -1.6% $373 1.60M -23.2% $596M Trimmed
11 META META PLATFORMS INC 4.34% -1.6% $563 1.05M -20.4% $593M Trimmed
12 ADP AUTOMATIC DATA PROCESSING IN 4.27% -1.8% $224 2.60M -32.5% $583M Trimmed
13 FTNT FORTINET INC 4.09% +0.2% $154 3.63M -41.0% $558M Trimmed
14 TSM TAIWAN SEMICONDUCTOR MANUFAC 4.02% +4.0% $478 1.15M new $548M New
15 IDXX IDEXX LABS INC 3.93% -2.5% $526 1.02M -30.4% $537M Trimmed
16 TXN TEXAS INSTRS INC 3.93% -0.0% $298 1.80M -31.4% $536M Trimmed
17 PM PHILIP MORRIS INTL INC 3.86% -2.7% $181 2.91M -43.0% $527M Trimmed
18 NFLX NETFLIX INC. 3.66% +3.7% $71 6.99M new $499M New
19 GEV GE VERNOVA INC 3.53% +3.5% $1.17K 410K new $481M New
20 APP APPLOVIN CORP 2.63% +2.6% $515 697K new $359M New
21 TJX TJX COS INC NEW 2.52% +2.5% $152 2.27M new $344M New
22 NXT NEXTPOWER INC 2.49% +2.5% $119 2.86M new $340M New
23 VEEV VEEVA SYS INC 1.06% +1.1% $177 817K new $145M New
24 YUM YUM BRANDS INC 0.65% +0.7% $160 556K new $88.90M New
25 MSCI MSCI INC 0.22% -0.1% $560 54K -17.3% $30.01M Trimmed
26 MEDP MEDPACE HLDGS INC 0.20% -0.0% $530 52K -16.4% $27.74M Trimmed
27 NTNX NUTANIX INC 0.20% +0.0% $51 538K -6.8% $27.43M Trimmed
28 BMI BADGER METER INC 0.19% +0.0% $148 175K +22.6% $25.91M Added
29 CLX CLOROX CO DEL 0.19% -0.0% $95 271K +5.5% $25.89M Added
30 ROL ROLLINS INC 0.19% -0.1% $42 620K +0.0% $25.88M Held
31 MANH MANHATTAN ASSOCIATES INC 0.18% +0.1% $139 173K +43.1% $24.09M Added
32 NSSC NAPCO SEC TECHNOLOGIES INC 0.17% +0.1% $38 607K +58.2% $23.05M Added
33 FICO FAIR ISAAC CORP 0.16% +0.2% $1.19K 18K new $21.45M New
34 SABR SABRE CORP 0.14% +0.0% $2 9.01M +0.0% $18.84M Held
35 IDCC INTERDIGITAL INC 0.13% +0.1% $283 60K new $17.08M New
36 ORLY OREILLY AUTOMOTIVE INC 0.11% +0.1% $92 163K new $14.98M New
37 VRT VERTIV HOLDINGS CO 0.10% -0.1% $335 42K -54.1% $14.03M Trimmed
38 VRSN VERISIGN INC 0.10% -0.1% $252 56K -50.9% $14.02M Trimmed
39 ADMA ADMA BIOLOGICS INC 0.10% -0.0% $8 1.65M +0.0% $13.81M Held
40 DOCS DOXIMITY INC 0.10% -0.0% $21 653K -5.6% $13.55M Trimmed
41 PAYC PAYCOM SOFTWARE INC 0.09% -0.1% $126 101K -54.1% $12.66M Trimmed
42 MTD METTLER TOLEDO INTERNATIONAL 0.00% -5.6% — 0 569K → 0 $0 Exited
43 ZTS ZOETIS INC 0.00% -3.6% — 0 3.88M → 0 $0 Exited
44 OTIS OTIS WORLDWIDE CORP 0.00% -1.6% — 0 2.73M → 0 $0 Exited
45 CPRXEUR CATALYST PHARMACEUTICALS INC 0.00% -0.2% — 0 845K → 0 $0 Exited
46 QLYS QUALYS INC 0.00% -0.2% — 0 226K → 0 $0 Exited
47 HD HOME DEPOT INC 0.00% -0.1% — 0 29K → 0 $0 Exited

* Price = reported value ÷ shares at quarter end (13F does not disclose cost basis). Δ wt = this position's share of the reported portfolio versus the prior quarter. Options are shown separately when filed.

This quarter's moves
  • UBER TECHNOLOGIES INC 4.73% · $645M
  • MASTERCARD INCORPORATED 4.69% · $639M
  • TAIWAN SEMICONDUCTOR MANUFAC 4.02% · $548M
  • NETFLIX INC. 3.66% · $499M
  • GE VERNOVA INC 3.53% · $481M
  • METTLER TOLEDO INTERNATIONAL was 5.59% · 569K sh
  • ZOETIS INC was 3.57% · 3.88M sh
  • OTIS WORLDWIDE CORP was 1.64% · 2.73M sh
  • CATALYST PHARMACEUTICALS INC was 0.16% · 845K sh
  • QUALYS INC was 0.15% · 226K sh
  • Filing detail
    Period2026-06-30
    Accepted14 Aug 2026 · 06:56 ET
    Filing lag45 days
    Form13F-HR
    Information rows41
    Quarters on file8
    Portfolio value
    Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026$23.46B Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 202642
    Quarterly history · 8 filings
    QuarterPeriod endReported valuePositionsLargestNewExitedFiledLag
    Q3 2026 2026-09-30 $12.92B 42 7.7% 2 1 16 Nov 2026 ET 47
    Q2 2026 2026-06-30 $13.65B 41 7.0% 13 6 14 Aug 2026 ET 45
    Q1 2026 2026-03-31 $12.83B 34 8.6% 1 4 15 May 2026 ET 45
    Q4 2025 2025-12-31 $17.12B 37 7.9% 2 0 17 Feb 2026 ET 48
    Q3 2025 2025-09-30 $19.80B 35 8.6% 0 4 14 Nov 2025 ET 45
    Q2 2025 2025-06-30 $23.02B 39 11.4% 3 2 14 Aug 2025 ET 45
    Q1 2025 2025-03-31 $21.97B 38 10.2% 2 2 15 May 2025 ET 45
    Q4 2024 2024-12-31 $23.46B 38 11.4% — — 14 Feb 2025 ET 45
    Track record · return since filing
    Paper return of each reported book
    Since Q4 2024
    +16.4%
    S&P 500 +24.1%
    Hit rate · latest book
    0%
    priced positions with positive return
    Priced coverage
    100%
    of reported stock value
    Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026Reported bookS&P 500
    Quarter by quarter
    QuarterBookS&P 500ExcessCoverageBest call
    Q3 2026 +0.0% +0.0% +0.0% 100% WAT +0.0%
    Q2 2026 +3.8% -4.1% +8.0% 100% MAR +19.8%
    Q1 2026 +20.1% +0.9% +19.1% 100% MTD +67.8%
    Q4 2025 +16.6% +9.6% +7.0% 99% WAT +41.8%
    Q3 2025 +14.0% +11.7% +2.3% 99% MAR +50.5%
    Q2 2025 +12.8% +16.7% -3.8% 99% MAR +61.7%
    Q1 2025 +15.6% +27.8% -12.2% 99% GOOGL +75.6%
    Q4 2024 +16.4% +24.1% -7.8% 100% MSFT +29.4%
    Copy-trade simulation
    Hypothetical strategy
    +28.9%
    8 rebalances
    S&P 500 same window
    +24.1%
    excess +4.7%

    Simulation: at each filing date, buy the manager's ten largest reported common-stock positions in equal weight; hold until the next filing. Prices are split- and dividend-adjusted closes. It ignores the 45-day disclosure lag's cost to a real copycat beyond the filing-date entry, taxes, fees and liquidity. It is a reading aid, not a backtest of the manager's fund.